These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7514954)

  • 1. Detection of HER-2/neu oncogene amplification in flow cytometry-sorted breast ductal cells by competitive polymerase chain reaction.
    Li BD; Harlow SP; Budnick RM; Sheedy DL; Stewart CC
    Cancer; 1994 Jun; 73(11):2771-8. PubMed ID: 7514954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of c-erbB-2 oncoprotein expression in breast tissue by multiparameter flow cytometry.
    Li BD; Bauer KD; Carney WP; Duda RB
    J Surg Res; 1993 Mar; 54(3):179-88. PubMed ID: 7682635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The c-erbB-2 oncogene amplification by competitive PCR in aneuploid cell clones flow sorted from breast cancer samples.
    Vona G; Caldini A; Sestini R; Rapi S; Bianchi S; Fanelli A; Pazzagli M; Orlando C
    Clin Chem Lab Med; 1999 Jun; 37(6):649-54. PubMed ID: 10475073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease.
    Press MF; Pike MC; Chazin VR; Hung G; Udove JA; Markowicz M; Danyluk J; Godolphin W; Sliwkowski M; Akita R
    Cancer Res; 1993 Oct; 53(20):4960-70. PubMed ID: 8104689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of eIF4E gene amplification in breast cancer by competitive PCR.
    Sorrells DL; Black DR; Meschonat C; Rhoads R; De Benedetti A; Gao M; Williams BJ; Li BD
    Ann Surg Oncol; 1998; 5(3):232-7. PubMed ID: 9607624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of HER-2/neu gene amplification in breast cancer using a novel polymerase chain reaction/ligase detection reaction technique.
    Nathanson DR; Nash GM; Chen B; Gerald W; Paty PB
    J Am Coll Surg; 2003 Sep; 197(3):419-25. PubMed ID: 12946797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HER-2/neu oncogene protein and prognosis in breast cancer.
    Tandon AK; Clark GM; Chamness GC; Ullrich A; McGuire WL
    J Clin Oncol; 1989 Aug; 7(8):1120-8. PubMed ID: 2569032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The significance of HER-2/neu/c-erbB-2 gene amplification in benign and malignant breast disease.
    Supanaranond K; Sukarayodhin S; Tanyakaset M; Balachandra K; Jullaksorn D; Rienkijkarn M; Hoisanka N; Tantivanich S
    Southeast Asian J Trop Med Public Health; 1997 Sep; 28(3):631-40. PubMed ID: 9561622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast biopsy nuclear pellets are a convenient source of DNA for routine determination of Her-2/neu gene amplification.
    Malka O; Pollack Y; Benharroch D; Cohen Y; Levy R; Yanai-Inbar I; Gopas J
    Breast Cancer Res Treat; 1991 Sep; 19(1):57-61. PubMed ID: 1684521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HER-2/neu gene copy number quantified by real-time PCR: comparison of gene amplification, heterozygosity, and immunohistochemical status in breast cancer tissue.
    Königshoff M; Wilhelm J; Bohle RM; Pingoud A; Hahn M
    Clin Chem; 2003 Feb; 49(2):219-29. PubMed ID: 12560343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of Her-2/Neu gene in breast cancer patients using real time-polymerase chain reaction (Q-PCR) and correlation with immunohistochemistry findings.
    Abdul Murad NA; Razak ZA; Hussain RM; Syed Hussain SN; Ko Ching Huat C; Che Md Ali SA; Abdullah N; Muhammad R; Ibrahim N; Jamal R
    Asian Pac J Cancer Prev; 2013; 14(3):1655-9. PubMed ID: 23679251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-myc, not HER-2/neu, can predict recurrence and mortality of patients with node-negative breast cancer.
    Schlotter CM; Vogt U; Bosse U; Mersch B; Wassmann K
    Breast Cancer Res; 2003; 5(2):R30-6. PubMed ID: 12631396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of HER-2 oncogene amplification in breast cancer by differential polymerase chain reaction from single cryosections.
    Friedrichs K; Lohmann D; Höfler H
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1993; 64(4):209-12. PubMed ID: 7904515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [HER-2 overexpression and gene amplification of advanced breast cancers determined by fluorescence in situ hybridization in fine needle aspiration specimens].
    Zhang Z; Zhao L; Guo H; Guo L; Ling Y; Xu X; Zhao H; Pan Q
    Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):183-7. PubMed ID: 24785277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of HER-2/neu oncoprotein expression in node-positive breast cancer. The influence of the pattern of immunostaining and adjuvant therapy.
    Têtu B; Brisson J
    Cancer; 1994 May; 73(9):2359-65. PubMed ID: 7909490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory assessment of the status of Her-2/neu protein and oncogene in breast cancer specimens: comparison of immunohistochemistry assay with fluorescence in situ hybridisation assays.
    Wang S; Saboorian MH; Frenkel E; Hynan L; Gokaslan ST; Ashfaq R
    J Clin Pathol; 2000 May; 53(5):374-81. PubMed ID: 10889820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of HER-2/neu oncogene amplification in primary breast cancer. The South Australian Breast Cancer Study Group.
    Seshadri R; Firgaira FA; Horsfall DJ; McCaul K; Setlur V; Kitchen P
    J Clin Oncol; 1993 Oct; 11(10):1936-42. PubMed ID: 8105035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of Her-2/neu oncogene in breast carcinoma by chromogenic in situ hybridization in cytologic specimens.
    Lin F; Shen T; Prichard JW
    Diagn Cytopathol; 2005 Dec; 33(6):376-80. PubMed ID: 16299744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amplification of HER-2(erbB-2/neu) oncogene as the most significant prognostic factor in a group of Russian breast cancer patients.
    Imyanitov EN; Chernitsa OI; Serova OM; Nikoforova IF; Pluzhnikova GF; Knyazev PG
    Neoplasma; 1993; 40(1):35-9. PubMed ID: 7688867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Her2/neu analysis in formalin-fixed, paraffin-embedded breast carcinomas: comparison of immunohistochemistry and multiparameter DNA flow cytometry.
    Leers MP; Hoop JG; Nap M
    Anticancer Res; 2003; 23(2A):999-1006. PubMed ID: 12820338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.